KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Leases (2019 - 2026)

GoodRx Holdings' Leases history spans 7 years, with the latest figure at $28.8 million for Q4 2025.

  • On a quarterly basis, Leases rose 3.65% to $28.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.8 million, a 3.65% increase, with the full-year FY2025 number at $28.8 million, up 3.65% from a year prior.
  • Leases hit $28.8 million in Q4 2025 for GoodRx Holdings, down from $29.7 million in the prior quarter.
  • Over the last five years, Leases for GDRX hit a ceiling of $34.9 million in Q1 2023 and a floor of $3.4 million in Q1 2025.
  • Historically, Leases has averaged $26.7 million across 5 years, with a median of $28.7 million in 2022.
  • Biggest five-year swings in Leases: soared 236.28% in 2023 and later tumbled 89.01% in 2025.
  • Tracing GDRX's Leases over 5 years: stood at $20.2 million in 2021, then crashed by 55.94% to $8.9 million in 2022, then soared by 236.28% to $29.9 million in 2023, then fell by 7.13% to $27.8 million in 2024, then grew by 3.65% to $28.8 million in 2025.
  • Business Quant data shows Leases for GDRX at $28.8 million in Q4 2025, $29.7 million in Q3 2025, and $30.7 million in Q2 2025.